Tirzepatide Clinical Trial NCT05822830
The National Library of Medicine has posted a new clinical trial for Tirzepatide.
The main purpose of this phase 3b study is to evaluate the efficacy and safety of tirzepatide compared with semaglutide in adult participants who have obesity or overweight with weight related comorbidities without Type 2 Diabetes. The study will last around 74 weeks.
Clinical Trial Information:
Study Start (Actual): 2023-04-21
Primary Completion (Estimated): 2024-11-06
Study Completion (Estimated): 2024-11-06
Enrollment (Estimated): 700
